Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
出版年份 2014 全文链接
标题
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
作者
关键词
-
出版物
CNS SPECTRUMS
Volume 19, Issue S1, Pages 35-53
出版商
Cambridge University Press (CUP)
发表日期
2014-11-18
DOI
10.1017/s1092852914000601
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Should cognitive impairment be included in the diagnostic criteria for schizophrenia?
- (2015) RICHARD S.E. KEEFE World Psychiatry
- Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis
- (2014) E. Bora et al. ACTA PSYCHIATRICA SCANDINAVICA
- Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia
- (2014) G. Fervaha et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cognitive Training in Mental Disorders: Update and Future Directions
- (2014) Matcheri S. Keshavan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive–behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias
- (2014) S. Jauhar et al. BRITISH JOURNAL OF PSYCHIATRY
- Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
- (2014) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Impact of primary negative symptoms on functional outcomes in schizophrenia
- (2014) G. Fervaha et al. EUROPEAN PSYCHIATRY
- The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis
- (2014) Gerald Jordan et al. JOURNAL OF CLINICAL PSYCHIATRY
- The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii
- (2014) Hui-Ling Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cognitive Remediation Therapy in Adolescents With Early-Onset Schizophrenia: A Randomized Controlled Trial
- (2014) Olga Puig et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study
- (2014) Alp Üçok et al. SCHIZOPHRENIA RESEARCH
- Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia
- (2014) Helena Fatouros-Bergman et al. SCHIZOPHRENIA RESEARCH
- A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA)
- (2014) Caili Wu et al. SCHIZOPHRENIA RESEARCH
- Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
- (2014) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Motivational Deficits and Cognitive Test Performance in Schizophrenia
- (2014) Gagan Fervaha et al. JAMA Psychiatry
- Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study
- (2013) C. Nordon et al. ACTA PSYCHIATRICA SCANDINAVICA
- Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study
- (2013) S. Kristian Hill et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
- (2013) Ann M. Kring et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive remediation improves cognition and good cognitive performance increases time to relapse – results of a 5 year catamnestic study in schizophrenia patients
- (2013) Wolfgang Trapp et al. BMC Psychiatry
- Does cognitive remediation for schizophrenia improve functional outcomes?
- (2013) Alice Medalia et al. CURRENT OPINION IN PSYCHIATRY
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Gender differences in first-episode psychosis at 5-year follow-up – two different courses of disease? Results from the OPUS study at 5-year follow-up
- (2013) A. Thorup et al. EUROPEAN PSYCHIATRY
- New renal anemia drugs: is there really anything new on the horizon?
- (2013) Jolanta Malyszko EXPERT OPINION ON EMERGING DRUGS
- Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysis
- (2013) Taro Kishi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: A preliminary open-label trial
- (2013) Hidenobu Suzuki et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Tools to Assess Negative Symptoms in Schizophrenia
- (2013) John M. Kane JOURNAL OF CLINICAL PSYCHIATRY
- Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases
- (2013) Robert A Lasser et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
- (2013) L Fredrik Jarskog et al. NEUROPSYCHOPHARMACOLOGY
- Neural substrates underlying effort computation in schizophrenia
- (2013) Gagan Fervaha et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Subjective Cognitive Complaints in Schizophrenia: Relation to Antipsychotic Medication Dose, Actual Cognitive Performance, Insight and Symptoms
- (2013) William Sellwood et al. PLoS One
- Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis
- (2013) Chuan Shi et al. PSYCHIATRY RESEARCH
- Meta-analysis of Cognitive Deficits in Ultra-high Risk to Psychosis and First-Episode Psychosis: Do the Cognitive Deficits Progress Over, or After, the Onset of Psychosis?
- (2013) E. Bora et al. SCHIZOPHRENIA BULLETIN
- Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
- (2013) Stephen R. Marder et al. SCHIZOPHRENIA RESEARCH
- Symptom dimensions and functional impairment in early psychosis: More to the story than just negative symptoms
- (2013) Daniel Fulford et al. SCHIZOPHRENIA RESEARCH
- Interview-based assessment of cognition in schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care
- (2013) Antonio Vita et al. SCHIZOPHRENIA RESEARCH
- Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: A randomized, double-blind, placebo-controlled study
- (2013) James B. Lohr et al. SCHIZOPHRENIA RESEARCH
- Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
- (2013) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: Challenges and therapeutic opportunities
- (2013) Jean-Pierre Lindenmayer et al. SCHIZOPHRENIA RESEARCH
- Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms
- (2013) Stephen Z. Levine et al. SCHIZOPHRENIA RESEARCH
- Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: A CATIE analysis
- (2013) Jonathan Rabinowitz et al. SCHIZOPHRENIA RESEARCH
- Rates and predictors of remission in first-episode schizophrenia within 1year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia
- (2013) Wolfgang Gaebel et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Symptomatic and functional remission in patients with first-episode psychosis
- (2012) S. Verma et al. ACTA PSYCHIATRICA SCANDINAVICA
- Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
- (2012) Xiang Yang Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses
- (2012) Juliano S Souza et al. CNS SPECTRUMS
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives
- (2012) Sara Poletti et al. PSYCHIATRY RESEARCH
- Prevalence of item level negative symptoms in first episode psychosis diagnoses
- (2012) John Lyne et al. SCHIZOPHRENIA RESEARCH
- Estrogen augmentation in schizophrenia: A quantitative review of current evidence
- (2012) Marieke J.H. Begemann et al. SCHIZOPHRENIA RESEARCH
- Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale
- (2012) Gregory P. Strauss et al. SCHIZOPHRENIA RESEARCH
- A brief cognitive–behavioural social skills training for stabilised outpatients with schizophrenia: A preliminary study
- (2012) Mar Rus-Calafell et al. SCHIZOPHRENIA RESEARCH
- Assessing the potential to use neurocognition to predict who is at risk for developing bipolar disorder: A review of the literature
- (2012) Doreen M. Olvet et al. Cognitive Neuropsychiatry
- The Psychosis High-Risk State
- (2012) Paolo Fusar-Poli et al. JAMA Psychiatry
- A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
- (2011) Til Wykes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia
- (2011) Paul M. Grant ARCHIVES OF GENERAL PSYCHIATRY
- Longitudinal Studies of Cognition in First Episode Psychosis: A Systematic Review of the Literature
- (2011) Vasilis P. Bozikas et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Quantifying Clinical Relevance in the Treatment of Schizophrenia
- (2011) Christoph U. Correll et al. CLINICAL THERAPEUTICS
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- Validation of a 4-item Negative Symptom Assessment (NSA-4): a short, practical clinical tool for the assessment of negative symptoms in schizophrenia
- (2011) Larry Alphs et al. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH
- Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
- (2011) Carrie K Jones et al. NEUROPSYCHOPHARMACOLOGY
- Negative Symptoms of Schizophrenia as Primary Target of Cognitive Behavioral Therapy: Results of the Randomized Clinical TONES Study
- (2011) S. Klingberg et al. SCHIZOPHRENIA BULLETIN
- Social Cognition as a Mediator Variable Between Neurocognition and Functional Outcome in Schizophrenia: Empirical Review and New Results by Structural Equation Modeling
- (2011) S. J. Schmidt et al. SCHIZOPHRENIA BULLETIN
- Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
- (2011) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial
- (2011) William V. Bobo et al. SCHIZOPHRENIA RESEARCH
- Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study
- (2011) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- The “Anhedonia Paradox” in Schizophrenia: Insights from Affective Neuroscience
- (2010) Diego A. Pizzagalli BIOLOGICAL PSYCHIATRY
- Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis
- (2010) Surendra P. Singh et al. BRITISH JOURNAL OF PSYCHIATRY
- Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder
- (2010) Michael S. Ritsner et al. JOURNAL OF CLINICAL PSYCHIATRY
- Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia
- (2010) Emmanuel Pinard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study
- (2010) O. Grynszpan et al. PSYCHOLOGICAL MEDICINE
- The Brief Negative Symptom Scale: Psychometric Properties
- (2010) Brian Kirkpatrick et al. SCHIZOPHRENIA BULLETIN
- The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?
- (2010) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Initial development and preliminary validation of a new negative symptom measure: The Clinical Assessment Interview for Negative Symptoms (CAINS)
- (2010) Courtney Forbes et al. SCHIZOPHRENIA RESEARCH
- The Cognitive Assessment Interview (CAI): Development and validation of an empirically derived, brief interview-based measure of cognition
- (2010) Joseph Ventura et al. SCHIZOPHRENIA RESEARCH
- The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study
- (2010) Robert S. Kern et al. SCHIZOPHRENIA RESEARCH
- Cognition at illness onset as a predictor of later functional outcome in early psychosis: Systematic review and methodological critique
- (2010) Kelly Allott et al. SCHIZOPHRENIA RESEARCH
- Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
- (2010) Richard S.E. Keefe et al. SCHIZOPHRENIA RESEARCH
- A Randomized, Controlled Trial of Computer-Assisted Cognitive Remediation for Schizophrenia
- (2009) Dwight Dickinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study
- (2009) Emre Bora et al. BRITISH JOURNAL OF PSYCHIATRY
- Deficit schizophrenia: An overview of clinical, biological and treatment aspects
- (2009) S. Galderisi et al. EUROPEAN PSYCHIATRY
- A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia
- (2009) Robert H. Pietrzak et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice
- (2009) Julio Bobes et al. JOURNAL OF CLINICAL PSYCHIATRY
- Short-Term Testosterone Augmentation in Male Schizophrenics
- (2009) Young-Hoon Ko et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cognitive deficits in recent-onset and chronic schizophrenia
- (2009) S.R. Sponheim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neurocognition in first-episode schizophrenia: A meta-analytic review.
- (2009) Raquelle I. Mesholam-Gately et al. NEUROPSYCHOLOGY
- A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for Clinicians
- (2009) I. M. Hurford et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
- (2009) L. B. Dixon et al. SCHIZOPHRENIA BULLETIN
- Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond
- (2009) E. Bora et al. SCHIZOPHRENIA BULLETIN
- Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study
- (2009) Silvana Galderisi et al. SCHIZOPHRENIA RESEARCH
- Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
- (2008) Anantha Shekhar et al. AMERICAN JOURNAL OF PSYCHIATRY
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
- (2008) G. Foussias et al. SCHIZOPHRENIA BULLETIN
- Emotional Experience in Patients With Schizophrenia Revisited: Meta-analysis of Laboratory Studies
- (2008) A. S. Cohen et al. SCHIZOPHRENIA BULLETIN
- Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder
- (2008) Jean-Marc Chianetta et al. SCHIZOPHRENIA RESEARCH
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects
- (2008) Eri Nakagami et al. SCHIZOPHRENIA RESEARCH
- Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial
- (2008) Shahin Akhondzadeh et al. SCHIZOPHRENIA RESEARCH
- Clinical global impression of cognition in schizophrenia (CGI-CogS): Reliability and validity of a co-primary measure of cognition
- (2007) Joseph Ventura et al. SCHIZOPHRENIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started